3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Neutrophils are a major source of the epithelial barrier disrupting cytokine Oncostatin M in mucosal airways disease

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          We have previously shown that Oncostatin M (OSM) is elevated in nasal polyps of chronic rhinosinusitis (CRS) patients, as well as in bronchoalveolar lavage (BAL) fluids after segmental allergen challenge in allergic asthmatics. We also showed in vitro that physiological levels of OSM impair barrier function in differentiated airway epithelium.

          Objective

          We sought to determine which hematopoietic or resident cell type(s) were the source of the OSM expressed in mucosal airways disease.

          Methods

          Paraffin-embedded NP sections were stained with fluorescence-labeled specific antibodies against OSM, GM-CSF and hematopoietic cell specific markers. Live cells were isolated from NP and matched blood samples for flow cytometric analysis. Neutrophils were isolated from whole blood, cultured with the known OSM inducers GM-CSF and FSTL1, and levels of OSM were measured in the supernatants. Bronchial biopsy sections from controls, moderate asthmatics and severe asthmatics were stained for OSM and neutrophil elastase.

          Results

          OSM staining was observed in NP, showed co-localization with neutrophil elastase (n=10), and did not co-localize with markers for eosinophils, macrophages, T cells or B cells (n=3–5). Flow cytometric analysis of NP (n=9) showed that 5.1±2% of CD45 + cells were OSM +, and of the OSM + cells, 56±7% were CD16 +Siglec8 , indicating neutrophil lineage. Only.6±.4% of CD45 + events from matched blood samples (n=5) were OSM +, suggesting that elevated OSM in CRS was locally stimulated and produced. A majority of OSM + neutrophils expressed Arginase 1 (72.5±12%), suggesting a N2 phenotype. GM-CSF was elevated in nasal polyp tissue compared to control, and was sufficient to induce OSM production (p<.001) in peripheral blood neutrophils in vitro. OSM + neutrophils were also observed at elevated levels in biopsies from patients with severe asthma. Additionally, OSM protein was elevated in induced sputum from asthmatic patients compared to controls (p<.05).

          Conclusions

          Neutrophils are a major source of OSM producing cells in CRS and severe asthma.

          Related collections

          Author and article information

          Journal
          1275002
          4431
          J Allergy Clin Immunol
          J. Allergy Clin. Immunol.
          The Journal of allergy and clinical immunology
          0091-6749
          1097-6825
          26 January 2017
          18 December 2016
          June 2017
          01 June 2018
          : 139
          : 6
          : 1966-1978.e9
          Affiliations
          [1 ]Division of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, III
          [2 ]Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, III
          [3 ]Divisions of Allergy and Clinical Immunology, Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, Md
          [4 ]Meakins-Christie Laboratories of McGill University and McGill University Health Center Research Institute, Montreal, Quebec, Canada
          Article
          PMC5529124 PMC5529124 5529124 nihpa845124
          10.1016/j.jaci.2016.10.039
          5529124
          27993536
          54cb45fe-dd8e-4a12-9716-34d5d3d71eab
          History
          Categories
          Article

          Epithelial barrier,Oncostatin M,Neutrophils,Chronic rhinosinusitis,Atopic asthma,Granulocyte-Monocyte Colony Stimulating Factor

          Comments

          Comment on this article